Published in
Elsevier, EBioMedicine, (66), p. 103327, 2021
DOI: 10.1016/j.ebiom.2021.103327
Links
Tools
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
Journal article published in 2021 by
K. Hoyer,
R. Hablesreiter,
Y. Inoue,
K. Yoshida,
F. Briest 
,
F. Christen,
N. Kakiuchi,
T. Yoshizato,
Y. Shiozawa,
Y. Shiraishi,
J. K. Striefler,
S. Bischoff,
P. Lohneis,
H. Putter,
O. Blau
and other authors.
,
F. Christen,
N. Kakiuchi,
T. Yoshizato,
Y. Shiozawa,
Y. Shiraishi,
J. K. Striefler,
S. Bischoff,
P. Lohneis,
H. Putter,
O. Blau
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 